A woman with advanced Alzheimer’s disease who had barely spoken for five years began recalling her past in a four-hour conversation just 19 hours after taking psilocybin-containing mushrooms, according to a published medical case report.
The remarkable improvement offers researchers a new lead in understanding how communication and other abilities might temporarily return in people with severe dementia.
The case, published in Frontiers in Neuroscience in May 2026, involved a Japanese-American woman in her 80s whose cognitive health had declined over a decade. Her speech had become mostly limited to single syllables. She needed help with daily activities, struggled to walk, and experienced urinary incontinence.
After receiving five grams of psilocybin-containing mushrooms under supervision, she experienced profuse sweating and a prolonged sleep-like state. Approximately 19 hours later, she awoke and began speaking spontaneously about memories from her life.
Her progress extended beyond conversation. In the following days, she recognized family members, walked independently, dressed herself, and regained bladder control. Researchers also recorded stronger emotional responses and renewed social interaction.
One month later, a second supervised session involving three grams was followed by further improvements in verbal expression, walking, and spontaneous humor.
During follow-up, the woman told researchers,
“It is pleasant to come here.”
Researchers Marcos Lago, Mariana Cerveira, and Joe Xavier Simonet reported that some improvements persisted for weeks.
Psilocybin affects serotonin signaling and alters communication across brain networks. Scientists are investigating whether these effects could help temporarily restore access to abilities affected by neurological decline.
Although the report documents a single patient and does not establish an Alzheimer’s treatment, the findings offer a promising direction for investigating ways to restore communication, independence, and quality of life in people living with advanced dementia.


















